Document is current

Article History

Received: 21 September 2023

Accepted: 6 May 2024

First Online: 4 June 2024

Declarations

:

: The study approved by the Ethics Committee of the medical Ethics committee of the Hunan Cancer Hospital (The ethical approval number was Scientific Research Fast review 2022[5]) in Changsha, Hunan Province, China. Despite being an anonymous cross-sectional survey, this study meticulously addressed ethical considerations. Firstly, prior to distributing the questionnaires, we diligently sought informed consent from the patients. Secondly, we provided a comprehensive explanation of the study’s purpose and significance to the patients. Lastly, we emphasized that patients’ responses were solely for the purposes of this study and that they had the freedom to discontinue their participation at any time.

: Not applicable.

: The authors declare no competing interests.